Diagnosis and Prognostic Significance of c-Met in Cervical Cancer: A Meta-Analysis

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases

(2015) Shunchao Yan et al.   Diagnostic Pathology

Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients

(2015) Nozomu Fuse et al.   Gastric Cancer

High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis

(2015) Cindy Neuzillet et al.   HISTOPATHOLOGY

Upregulation of HGF and c-MET is Associated with Subclinical Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma

(2014) Bon Seok Koo et al.   ANNALS OF SURGICAL ONCOLOGY

Overexpression of c-Met increases the tumor invasion of human prostate LNCaP cancer cells in vitro and in vivo

(2014) YILI HAN et al.   Oncology Letters

Targeting the MET receptor tyrosine kinase in non-small cell lung cancer: emerging role of tivantinib

(2014) Patrick Ma et al.   Cancer Management and Research

Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry

(2013) Bo Kim et al.   Journal of Translational Medicine

Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma

(2012) Yong Cheng et al.   HUMAN PATHOLOGY

Worldwide burden of cervical cancer in 2008

(2011) M. Arbyn et al.   ANNALS OF ONCOLOGY

Epithelial-Mesenchymal Transition in Cervical Cancer: Correlation with Tumor Progression, Epidermal Growth Factor Receptor Overexpression, and Snail Up-Regulation

(2008) M.-Y. Lee et al.   CLINICAL CANCER RESEARCH